Applied Clinical Trials: Small Biopharma and CROs: Seeking Stronger Synergies
Many emerging biopharmaceutical companies hire contract research organizations (CROs) because of limited staffing and regulatory experience to help them navigate the regulatory pathway. CROs are instrumental in helping these biopharma overcome obstacles such as clinical trial timeline delays, out-of-scope change orders and cost overruns, especially for smaller biotech companies who cannot afford drastic missteps.
All of the above highlight the need to find a CRO that will be the right fit and consistently responsive to clients’ needs.
To propel the biotech companies we partner with, TD2 utilizes a “value-add” approach, where we strive to supplement their capabilities while filling in the gaps in the internal infrastructure to help develop their plan and process every step of the way.
Hear from TD2 president and CEO, Stephen Gately, and chief operating officer, Tara Frank, about how TD2 uses their suite of capabilities to maximize the CRO and emerging biopharma relationship in this recent Applied Clinical Trials article.
About Translational Drug Development (TD2)
TD2 is an oncology development organization that provides innovative services for oncology-focused companies. Using a dedicated team of professionals with broad experience and understanding in drug development, TD2 is uniquely positioned to support improved and accelerated development of medicines for life-threatening oncology diseases. TD2 applies rigorous and high-throughput translational preclinical development, combined with regulatory affairs expertise, to customize clinical trial design and execution. TD2’s suite of capabilities encourages the timely selection of patient populations who are most likely to benefit from a new agent, and the rapid identification of clinically significant endpoints. TD2 is committed to reducing the risks and uncertainty inherent in the drug development process and to the acceleration of patient access to promising treatments. For more information, visit TD2inc.com.